Last $2.19 USD
Change Today -0.01 / -0.45%
Volume 76.9K
As of 5:20 PM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott Daniel Cormack

Founder, Chief Executive Officer, President, Treasurer, Secretary and Director, OncoGenex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 2 different industries.

See Board Relationships
49$1,588,613
As of Fiscal Year 2013

Background*

Mr. Scott Daniel Cormack has been the Chief Executive Officer and President of OncoGenex Pharmaceuticals, Inc. since August 2008 and serves as its Chief Financial Officer. Mr. Cormack founded OncoGenex Pharmaceuticals Inc. in 2000. He has been a Secretary and Treasurer of OncoGenex Pharmaceuticals Inc. since January 31, 2013. He served as the Secretary of OncoGenex Pharmaceuticals Inc. since February 2010 and its Principal Financial Officer. He has over 10 years of diverse ...

Read Full Background

Corporate Headquarters*

1522- 217th Place SE
Bothell, Washington 98021

United States

Phone: 425-686-1500
Fax: --

Board Members Memberships*

Director
2008-Present
Founder, Chief Executive Officer, President, Treasurer, Secretary and Director

Education*

BS
University Of Alberta

Other Affiliations*

Annual Compensation*

Salary$503,719
Total Annual Compensation$503,719

Stock Options*

Restricted Stock Awards$552,986
Exercisable Options181,563
Unexercisable Options58,437
Total Number of Options240,000

Total Compensation*

Total Annual Cash Compensation$711,562
Total Short Term Compensation$503,719
Other Long Term Compensation$552,986
Total Calculated Compensation$1,588,613
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $2.19 USD -0.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.